STADA purchases British OTC manufacturer Thornton & Ross

16/08/2013


STADA purchases British OTC manufacturer Thornton & Ross

Bad Vilbel, August 16, 2013

STADA Arzneimittel AG today signed and concluded a contract for the purchase of Thornton & Ross, a British OTC manufacturer located in Huddersfield, after STADA and the owners had already announced exclusive contract negotiations on this issue on August 6, 2013 (see ad hoc release of August 6, 2013).


The purchase price amounts to 221,117,910 British pounds (at current exchange rate approximately 259,223,810 Euro) in cash. This corresponds to 193 million British pounds (at current exchange rate approximately 226 million Euro) on a so-called cash and debt-free basis. Thornton & Ross has a number of well-known prescription-free (OTC) branded products for a wide variety of indications – among other things, cold, pain and dermatology.


Sales will presumably be consolidated in the STADA Group as of September 1, 2013. From that date, the transaction will also make a positive contribution to net income.


For more information, please contact:
STADA Arzneimittel AG
Corporate Communications
D-61118 Bad Vilbel
Tel.: +49 6101 603-113
Fax: +49 6101 603-506
e-mail: communications@stada.de

Download in PDF format

Share:

Related Posts

STADA Arzneimittel AG: Supervisory Board of STADA Arzneimittel AG appoints Peter Goldschmidt as new Chairman of the Executive Board as of September 1, 2018
The Supervisory Board of STADA Arzneimittel AG appointed Peter Goldschmidt today as new Chairman of the Executive Board as of September 1, 2018.
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throat
STADA: Significant renewal of Supervisory Board brought forward by two years – Annual General Meeting 2016 postponed to August 26, 2016
STADA: Significant renewal of Supervisory Board brought forward by two years – Annual General Meeting 2016 postponed to August 26, 2016